326 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
PNC Financial (PNC) Q4 Earnings Beat on Lower Cost & Provisions https://www.zacks.com/stock/news/2211690/pnc-financial-pnc-q4-earnings-beat-on-lower-cost-provisions?cid=CS-ZC-FT-analyst_blog|earnings_article-2211690 Jan 17, 2024 - PNC Financial's (PNC) Q4 earnings surpass estimates on decent expense-control efforts and a decline in provision for credit losses.
Albemarle (ALB) Trims CapEx, Optimizes Costs Amid Market Dynamics https://www.zacks.com/stock/news/2212251/albemarle-alb-trims-capex-optimizes-costs-amid-market-dynamics?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2212251 Jan 18, 2024 - Albemarle (ALB) adjusts its course in the lithium value chain, optimizing costs, reducing capital expenditure and emphasizing short-term growth while safeguarding prospects.
Can Higher Costs Affect HCA Healthcare's (HCA) Q4 Earnings? https://www.zacks.com/stock/news/2215093/can-higher-costs-affect-hca-healthcare-s-hca-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2215093 Jan 24, 2024 - HCA Healthcare's (HCA) fourth-quarter results are likely to reflect increased admissions and a lower average length of stay.
Eastman Chemical (EMN) Gains on Cost Cuts and Innovation https://www.zacks.com/stock/news/2216558/eastman-chemical-emn-gains-on-cost-cuts-and-innovation?cid=CS-ZC-FT-analyst_blog|zer_report_update-2216558 Jan 26, 2024 - Eastman Chemical (EMN) benefits from cost-management actions and innovation amid challenges from soft demand and consumer de-stocking in certain markets.
Top Research Reports for Meta Platforms, Berkshire Hathaway & Costco Wholesale https://www.zacks.com/commentary/2217106/top-research-reports-for-meta-platforms-berkshire-hathaway-costco-wholesale?cid=CS-ZC-FT-research_daily-2217106 Jan 29, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Berkshire Hathaway Inc. (BRK.B) and Costco Wholesale Corporation (COST).
MetLife (MET) Q4 Earnings Miss on High Costs & Weak EMEA Unit https://www.zacks.com/stock/news/2219706/metlife-met-q4-earnings-miss-on-high-costs-weak-emea-unit?cid=CS-ZC-FT-analyst_blog|earnings_article-2219706 Feb 01, 2024 - MetLife's (MET) Q4 results took a hit from increased policyholder benefits and claims, partly offset by expanding volumes in the Group Benefits and Latin America units.
McCormick (MKC) Gains on Innovation & Pricing Amid Cost Woes https://www.zacks.com/stock/news/2222618/mccormick-mkc-gains-on-innovation-pricing-amid-cost-woes?cid=CS-ZC-FT-analyst_blog|rank_focused-2222618 Feb 07, 2024 - McCormick's (MKC) strategic focus on pricing, innovation and efficiency underpins its industry leadership and growth despite facing inflation and volume challenges.
3 HMO Stocks in Focus Despite High Tech Costs & Nursing Shortage https://www.zacks.com/commentary/2224560/3-hmo-stocks-in-focus-despite-high-tech-costs-nursing-shortage?cid=CS-ZC-FT-industry_outlook-2224560 Feb 12, 2024 - Growing customer base and M&A strategies are likely to aid the Medical-HMO industry. However, escalating expenses and a dearth in the availability of medical personnel are concerning. Stocks like CI, CNC and MOH are likely to navigate the industry storms.
ETFs & Stocks to Gain on Gift Ideas This Valentine's Day https://www.zacks.com/stock/news/2226384/etfs-stocks-to-gain-on-gift-ideas-this-valentine-s-day?cid=CS-ZC-FT-etf_news_and_commentary-2226384 Feb 14, 2024 - The United States will be showered with love as 53% of its adults are planning to celebrate this Valentine's Day.
SMCI: Shades of QCOM in 99'? https://www.zacks.com/commentary/2227242/smci-shades-of-qcom-in-99?cid=CS-ZC-FT-investment_ideas-2227242 Feb 16, 2024 - The stock market is notoriously hard to predict, especially when calling tops. However, SMCI has all the ingredients of a classic Climax Top pattern. Stock Strategist Andrew Rocco explains.

Pages: 1...1314151617181920212223...33

<<<Page 18>